Nesprin1 deficiency is associated with poor prognosis of renal cell carcinoma and resistance to sunitinib treatment.
Fukushima T, Kobatake K, Miura K, Takemoto K, Yamanaka R, Tasaka R, Kohada Y, Miyamoto S, Sekino Y, Kitano H, Goto K, Ikeda K, Goriki A, Hieda K, Kaminuma O, Hinata N.
Fukushima T, et al. Among authors: yamanaka r.
Oncology. 2024 Mar 5. doi: 10.1159/000536539. Online ahead of print.
Oncology. 2024.
PMID: 38442705